top of page

About The ROS1ders

The ROS1ders was founded in 2015 by a small group of ROS1+ lung cancer patients.  We are now the largest collection of ROS1+ patients and caregivers in the world, with hundreds of members from dozens of countries.  Initially, we partnered with other nonprofits to drive research into ROS1+ cancers of all types. In 2019  we incorporated and became The ROS1ders, Inc., a 501(c)(3) nonprofit corporation run by volunteers, most of whom are patients or caregivers living with ROS1+ cancer.

Our Mission

The ROS1ders is a global group of patients and caregivers
living with ROS1+ cancer. We seek to improve outcomes for
all ROS1+ cancers through community, education, and research.


  • Private Facebook group for patients and caregivers to navigate patient care and share research and treatment updates—to join, complete this form and ask to join the group

  • Online Zoom MeetUps to share experiences and knowledge

  • In-person MeetUps (coming soon)

ROS1ders at CU GRACE Forum Aug 2017 (Eric Goldman) -- cropped3.jpg


  • Website shares evidence-based information on ROS1+ cancer, treatments, ROS1 clinicians, clinical trials, and living with our disease

  • Social media posts share news about ROS1+ cancer

  • Newsletter highlights progress and patient and caregiver tips

  • Webinars and conference

  • presentations disseminate information

Camidge with Merel and LisaG at WCLC2017 (cropped).jpg


  • Members donate fresh tumor specimens to create cancer models

  • Pursue real-world data collection 

  • Host gatherings of ROS1 experts to sustain and promote research 

  • Collaborate with key players to improve patient care and access to clinical trials

  • Fund seed grants to attract new research for ROS1+ cancer

cell lines.PNG

Our Leadership Team


Janet Freeman-Daily
Co-founder, President,
Board Chair

Janet is a cancer patient research advocate and activist who translates the experience and science of cancer for others.  She was diagnosed with advanced lung cancer in 2011 and metastatic ROS1+  lung cancer in 2012. She collaborates, writes, and speaks with cancer organizations both internationally and within the USA, and blogs at Gray Connections.  Janet previously worked as a aerospace systems engineer. 


Lisa Goldman
Co-founder, Vice President,
Board Member

Lisa is a cancer patient/advocate. She was diagnosed with ROS1+ Stage IV NSCLC in 2014. She is a member of the Pfizer Lung Cancer Steering Committee and a Patient Advocate for the Lung Cancer Foundation of America. She speaks at medical conferences both internationally and in the USA and blogs at Every Breath I Take. Lisa previously worked as a fitness instructor and lawyer.  

Lisa Bowden.jpg

Lisa Bowden
Board Member

Lisa is a business consultant with the City of Chicago in Business Affairs and Consumer Protection. She has family members who have had cancer, a personal connection to The ROS1ders community, and both passion and experience with healthcare advocacy. She holds an MBA as well as an MPA in non-profit/public/organizational/ management.


Upal Basu Roy
Board Member

Upal Basu Roy is Executive Director of Research at LUNGevity Foundation, where he oversees the research strategy of LUNGevity Foundation. As a patient research advocate, Upal works with national organizations such as the US FDA and the NCI, patient advocacy groups, and pharma partners.  Upal has over 10 years of translational cancer research experience in the laboratory. He received a Ph.D. in Cancer Biology and an MPH in Global Health Policy and Management.

Steve Weiss.PNG

Steven Weiss
Board Member

Steve J. Weiss is an attorney with Hertz Schram who specializes in employment and business disputes as well as personal injury/medical malpractice.  He received his JD from the University of Miami School of Law in 1980, and has been honored as one of the "Best Lawyers in America." He is married to Karen Weiss, who has stage IV ROS1+ cancer.

Amie P profile pic_edited.jpg

Amie Parker
Board Member

Amie Parker is an educator working to support teachers with their classroom technology.  She was diagnosed with ROS1+ Stage IV NSCLC in 2017.    She is active in the ROS1der community and provides support and resources to other ROS1ders.

bottom of page